Retirement Planning Co of New England Inc. reduced its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 8.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,952 shares of the specialty pharmaceutical company’s stock after selling 2,625 shares during the […]
StockNews.com lowered shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday. Separately, Piper Sandler lifted their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on […]
StockNews.com downgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a hold rating in a research note released on Friday morning. Separately, Piper Sandler lowered their target price on Supernus Pharmaceuticals from $43.00 to $42.00 and set an overweight rating on the stock in a research note on Wednesday, October […]
Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) had its price objective decreased by Piper Sandler from $43.00 to $42.00 in a research note issued to investors on Wednesday, Benzinga reports. Piper Sandler currently has an overweight rating on the specialty pharmaceutical company’s stock. Separately, StockNews.com raised shares of Supernus Pharmaceuticals from a hold rating to a […]
Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Hold at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.